Ascites

• 

  Subject Areas on Research

  • 211At radiocolloid therapy: further observations and comparison with radiocolloids of 32P, 165Dy, and 90Y. 
  • A carcinoembryonic antigen (CEA) binding protein from ascites influences CEA uptake by macrophages. 
  • A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA). 
  • A rare case of isolated congenital right ventricular inflow obstruction due to the presence of an intraventricular muscular shelf. 
  • Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation. 
  • An effusion-based presentation of ALK- anaplastic large cell lymphoma. 
  • Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells. 
  • Ascites as a marker for the hyperdynamic heart of Laennec's cirrhosis. 
  • Ascites in hepatitis C liver transplant recipients frequently occurs in the absence of advanced fibrosis. 
  • Ascites or pleural effusion? CT differentiation: four useful criteria. 
  • CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade. 
  • Cervical adenoid cystic carcinoma associated with ascites. 
  • Clinical problem-solving. A key miscommunication--an 81-year-old woman presented to the emergency department with increasing abdominal distention, nausea, and vomiting. 
  • Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplant Consortium Joint Working Committees on Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents: Part 2-Focus on Ascites, Fluid and Electrolytes, Renal, and Transfusion Issues. 
  • Diagnostic accuracy of intra-abdominal fluid collection characterization in the era of multidetector computed tomography. 
  • Differential diagnosis of ascites. 
  • Distal ventriculoperitoneal shunt failure secondary to Clostridium difficile colitis. 
  • Does this patient with liver disease have cirrhosis? 
  • Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. 
  • Effects of murine cytomegalovirus infection on the immune response to a tumor allograft. 
  • Elevated serum CA-125 levels: hepatitis or ascites? 
  • Evaluation of New-Onset Ascites. 
  • Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer. 
  • Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target. 
  • Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. 
  • Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. 
  • IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. 
  • Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study. 
  • Incarceration of umbilical hernia following transjugular intrahepatic portosystemic shunt for the treatment of ascites. 
  • Indwelling catheters for the management of refractory malignant ascites: a systematic literature overview and retrospective chart review. 
  • Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses. 
  • Leukemic ascites complicating acute myelomonoblastic leukemia. 
  • Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines. 
  • Mechanisms of Ascites Development-Reply. 
  • Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. 
  • No Increased Mortality After TIPS Compared with Serial Large Volume Paracenteses in Patients with Higher Model for End-Stage Liver Disease Score and Refractory Ascites. 
  • Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. 
  • Outcomes after esophagectomy: a ten-year prospective cohort. 
  • Ovarian hyperstimulation syndrome: A review for emergency clinicians. 
  • Pancreatitis-associated ascitic fluid: effect on the oxygen consumption of liver cells. 
  • Portacaval shunts for ascites: another perspective. 
  • Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease. 
  • Quantitating bedside diagnosis: clinical evaluation of ascites. 
  • Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression. 
  • Scintigraphy, ultrasound and CT scanning of the liver. 
  • Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. 
  • Spontaneous regression of fetal ascites in utero in an adolescent. 
  • Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer. 
  • Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78. 
  • Technology Assessment Status Evaluation update: transvenous intrahepatic portosystemic shunt (TIPS). April, 1997. ASGE. American Society for Gastrointestinal Endoscopy. 
  • Telomerase activity in human ovarian carcinoma. 
  • The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations. 
  • The rational clinical examination. Does this patient have ascites? How to divine fluid in the abdomen. 
  • The role of liver transplantation in the management of portal hypertension. 
  • The sonographic appearance of anomalous circumrenal vein mimicking perirenal fluid collection. 
  • The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy. 
  • Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites. 
  • Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score. 
  • Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients. 
  • Ultrasound and gallium for the diagnosis of abdominal and pelvic abscesses. 
  • Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions. 
  • Vasodilatory state of decompensated cirrhosis: relation to hepatic dysfunction, ascites, and vasoactive substances. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Cianciolo, George James, Associate Professor Emeritus of Pathology, Pathology
  • Sullivan, Daniel Carl, Professor Emeritus of Radiology, Radiology